Boston Scientific (BSX) Current Deferred Tax Assets (2009 - 2019)

Boston Scientific (BSX) has 11 years of Current Deferred Tax Assets data on file, last reported at $195.0 million in Q4 2019.

• For the quarter ending Q4 2019, Current Deferred Tax Assets rose 124.14% year-over-year to $195.0 million; the trailing twelve-month figure through Dec 2019 stood at $195.0 million (up 124.14% YoY), and the FY2019 full-year result was $195.0 million, up 124.14% from the prior year.
• Current Deferred Tax Assets climbed to $195.0 million in Q4 2019, from $189.0 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $496.0 million in Q4 2015 to a low of $43.0 million in Q3 2018.
• A 5-year average of $153.0 million and a median of $81.0 million in 2016 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets sank 84.88% in 2016 and jumped 339.53% in 2019, its largest moves.
• Tracing BSX's Current Deferred Tax Assets over 5 years: stood at $496.0 million in 2015, then slumped by 84.88% to $75.0 million in 2016, then slipped by 12.0% to $66.0 million in 2017, then soared by 31.82% to $87.0 million in 2018, then jumped by 124.14% to $195.0 million in 2019.
• Business Quant data shows BSX's Current Deferred Tax Assets at $195.0 million in Q4 2019, $189.0 million in Q3 2019, and $175.0 million in Q2 2019.